Z
Zhijian Cao
Researcher at Wuhan University
Publications - 175
Citations - 4033
Zhijian Cao is an academic researcher from Wuhan University. The author has contributed to research in topics: Peptide & Scorpion toxin. The author has an hindex of 32, co-authored 143 publications receiving 3334 citations.
Papers
More filters
Journal ArticleDOI
The genome of Mesobuthus martensii reveals a unique adaptation model of arthropods
Zhijian Cao,Yao Yu,Yingliang Wu,Pei-Pei Hao,Zhiyong Di,Yawen He,Zongyun Chen,Weishan Yang,Zhiyong Shen,Xiaohua He,Jia Sheng,Xiaobo Xu,Bohu Pan,Jing Feng,Xiaojuan Yang,Wei Hong,Wenjuan Zhao,Zhongjie Li,Kai Huang,Tian-tian Li,Yimeng Kong,Hui Liu,Dahe Jiang,Binyan Zhang,Jun Hu,Youtian Hu,Bin-Bin Wang,Jianliang Dai,Bi-Feng Yuan,Yu-Qi Feng,Wei Huang,Xiaojing Xing,Guoping Zhao,Xuan Li,Yixue Li,Wenxin Li +35 more
TL;DR: The genome sequence of Mesobuthus martensii is reported, containing 32,016 protein-coding genes, the most among sequenced arthropods, and reveals a unique adaptation model of arthropod, offering new insights into the genetic bases of the living fossils.
Journal ArticleDOI
Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders
Zhongchun Liu,Fan Zhu,Gaohua Wang,Zheman Xiao,Jihua Tang,Wanhong Liu,Huiling Wang,Hao Liu,Xiaoping Wang,Yingliang Wu,Zhijian Cao,Wenxin Li +11 more
TL;DR: The results show that the rs242941 G/G genotype and homozygous GAG haplotype of the three single-nucleotide polymorphisms (SNPs) are associated with fluoxetine therapeutic response in MDD patients of high-anxiety (HA).
Journal ArticleDOI
Structural Basis of a Potent Peptide Inhibitor Designed for Kv1.3 Channel, a Therapeutic Target of Autoimmune Disease
TL;DR: The design of a new peptide inhibitor that is potent and selective for Kv1.3, and the successful design of ADWX-1 suggests that rational design based on the structural model of the peptide-channel complex should accelerate the development of diagnostic and therapeutic agents for human channelopathies.
Journal ArticleDOI
Hg1, Novel Peptide Inhibitor Specific for Kv1.3 Channels from First Scorpion Kunitz-type Potassium Channel Toxin Family *
Zongyun Chen,Youtian Hu,Weishan Yang,Yawen He,Jing Feng,Bin Wang,Ruiming Zhao,Jiuping Ding,Zhijian Cao,Wenxin Li,Yingliang Wu +10 more
TL;DR: The first scorpion Kunitz-type potassium channel toxin family with three groups and seven members is identified, of which a novel inhibitor, Hg1, is specific for Kv1.3 channel, and their structural and functional diversity strongly suggest that Kunitzer-type toxins are a new source to screen and design potential peptides for diagnosing and treating Kv 1.3-mediated autoimmune diseases.
Journal ArticleDOI
Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.
Qiaoli Li,Zhenhuan Zhao,Dihan Zhou,Yaoqing Chen,Yaoqing Chen,Wei Hong,Luyang Cao,Jingyi Yang,Yan Zhang,Wei Shi,Zhijian Cao,Yingliang Wu,Huimin Yan,Huimin Yan,Wenxin Li +14 more
TL;DR: Evidence is provided that host defense peptides from scorpion venom can be modified for antiviral activity by rational design and represents a practical approach for developing broad-spectrum antiviral agents, especially against RNA viruses.